International Journal of Cancer
-
Publication Venue For
- Epigenetic determinants of ovarian clear cell carcinoma biology.. 135:585-597. 2014
- Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors.. 132:2339-2348. 2013
- The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.. 130:20-28. 2012
- Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas.. 129:111-121. 2011
- Recombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas.. 127:598-611. 2010
- IDH1 and IDH2 hotspot mutations are not found in canine glioma.. 127:245-246. 2010
- Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo.. 126:2893-2903. 2010
- Targeting slow-proliferating ovarian cancer cells.. 126:2448-2456. 2010
- Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.. 126:1378-1389. 2010
- IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.. 125:2673-2678. 2009
- Re: KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer (Int J Cancer 123: 2239-2246, 2008).. 124:2243-2244. 2009